Equity and intellectual property (IP) rights are – unsurprisingly – the most important and trickiest issues facing countries negotiating the terms on which the next global pandemic will be addressed. This emerged at a World Health Organization (WHO) briefing on Thursday addressed by Precious Matsoso, co-chair of the Intergovernmental Negotiating Body (INB) crafting a pandemic […] Continue reading ->
The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading ->
The conspiracy-based anti-science attacks on scientists and vaccines that proliferated during the COVID-19 pandemic in the US are likely to have chilling, long-term effects on biomedicine, according to Professor Peter Hotez, Dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston.  The biggest casualty may be childhood vaccinations, leading to […] Continue reading ->
By the end of 2022, COVID-19 vaccines delivered by the global vaccine access initiative, COVAX,  helped to avert 2.7 million deaths across 92 lower-income countries, according a new report based on modelling by researchers from Imperial College London. COVAX’s biggest success was in low-income countries, where its vaccines were responsible for three-quarters of all deaths […] Continue reading ->
Four more African countries will be introducing pneumococcal conjugate vaccine (PCV) into their routine immunization schedules – as other countries across Africa said they would ramp up and revitalize childhood vaccination programmes that were hit hard by the COVID pandemic.  In commitments announced this week at the 2nd Global Forum on Childhood Pneumonia in Madrid […] Continue reading ->